EUVIMEDEUVIMED entdecken
Crossref

Anti-Spike IgG against COVID-19 three months after the end of the pandemic in Northeast of Portugal

Duro, Inês, Maria Conceição Manso, Cristina Couto, Mary Duro

Science Letters · 03.09.2024

DOI: 10.48797/sl.2024.269 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Letters, erschienen am 03.09.2024. Verfasst von Duro und 4 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of new COVID-19 strains and variants and immune escape from vaccines forces reflection on the need to continue vaccinating the entire population. This study intends to monitor and understand the reinfection in recently vaccinated people. The amount of anti-Spike IgG, the number of vaccine doses, and infections/reinfections in 82 volunteers, three months after the declaration of the end of the COVID-19 pandemic, was evaluated. All participants, asymptomatic at the time, presented IgG, including those who had no infection or vaccination (n = 3). Those vaccinated showed high levels of antibodies, even 36 months after the last booster. There was no significant difference in the immunological status with the type of vaccine, age, and sex, although women and older people had higher median IgG values. A significant positive correlation was observed between vaccine doses and IgG (rs = 0.373; p < 0.001). Women vaccinated before coming into contact with the virus showed higher antibody levels (16607 vs. 6233; p = 0.012). This study suggests women’s immune systems are more effective at fighting the virus. It also supports the effectiveness of vaccines on the humoral response. However, the timing of infections is inconsistent with the expected immunity. Therefore, continuation of booster doses is questionable except for immunocompromised patients.

Schlagwörter

COVID-19 pandemicSARS-CoV-2 spike proteinanti-spike IgGhumoral immune responseCOVID-19 vaccinationbooster vaccinationreinfectionsex differences in immunityage differences in immunityantibody persistence

Zitieren

APA

Duro, Inês, Manso, M. C., Couto, C., & Duro, M. (2024). Anti-Spike IgG against COVID-19 three months after the end of the pandemic in Northeast of Portugal. Science Letters. https://doi.org/10.48797/sl.2024.269

Vancouver

Duro, Inês, Manso MC, Couto C, Duro M. Anti-Spike IgG against COVID-19 three months after the end of the pandemic in Northeast of Portugal. Science Letters. 2024. doi:10.48797/sl.2024.269

BibTeX
@article{Duro2024,
  author = {Duro and Inês and Manso, Maria Conceição and Couto, Cristina and Duro, Mary},
  title = {Anti-Spike IgG against COVID-19 three months after the end of the pandemic in Northeast of Portugal},
  journal = {Science Letters},
  year = {2024},
  doi = {10.48797/sl.2024.269}
}
Kostenlos starten →